BioSpace News Archive

The Honourable Mary Ng, Canadian Minister of Small Business and Export Promotion, announced in August an investment of up to $100,000 in Everest Clinical Research (“Everest”) through the Women Entrepreneurship Fund.

Lena Winstedt, PhD, Head of Science at Hansa Biopharma, will present results from a pooled analysis of Phase 2 trials with imlifidase for desensitization in sensitized kidney transplant patients

Constellation Alpha Capital Corp. and DermTech Operations, Inc. announced that they have completed their previously announced business combination.

Allergan plc announced that the Company and its U.S. subsidiaries have reached a settlement with plaintiffs scheduled for trial in October 2019 in the federal opioid multidistrict litigation.

Tolk Chiropractic & Wellness launches Tolk Rewards, a digital rewards program that gives back to loyal patients

Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com (“Liberty” or the “Company”), a provider of high quality cannabis, announced today that it will open its 17th dispensary in Panama City, Florida on September 3, 2019, subject to approval from the Florida Department of Health.

Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that management will be presenting at the H.C. Wainwright 21st Annual Global Investment Conference to be held September 8-10, 2019, at the Lotte New York Palace Hotel in New York City.

Fresenius Kabi announced today the immediate availability in the United States of Phenylephrine Hydrochloride Injection, USP.

WntResearch and The Sage Group have initiated a collaboration to accelerate the process of identifying and engaging potential partners prior to readout of the on-going Phase 2 study with Foxy-5.